These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Laboratory indicators of endothelial involvement in rheumatic diseases associated with vasculitis in children]. Dolezalová P; Telekesová P; Nĕmcová D; Bĕlorová J; Kvasnicka J; Hoza J Cas Lek Cesk; 2003; 142(10):615-9. PubMed ID: 14635427 [TBL] [Abstract][Full Text] [Related]
4. von Willebrand factor antigen as an acute phase reactant and marker of endothelial cell injury in connective tissue diseases: a comparison with CRP, rheumatoid factor, and erythrocyte sedimentation rate. Blann AD Z Rheumatol; 1991; 50(5):320-2. PubMed ID: 1723232 [TBL] [Abstract][Full Text] [Related]
5. von Willebrand factor in the plasma of patients with rheumatic diseases. Duţu A; Rus V; Boloşiu HD; Parasca I; Cristea A; Malide D Med Interne; 1989; 27(4):273-8. PubMed ID: 2617082 [TBL] [Abstract][Full Text] [Related]
6. Increased Fas and Bcl-2 expression on peripheral blood T and B lymphocytes from juvenile-onset systemic lupus erythematosus, but not from juvenile rheumatoid arthritis and juvenile dermatomyositis. Liphaus BL; Kiss MH; Carrasco S; Goldenstein-Schainberg C Clin Dev Immunol; 2006; 13(2-4):283-7. PubMed ID: 17162369 [TBL] [Abstract][Full Text] [Related]
7. Mucoproteins, sialic acid and haptoglobin in collagenoses in children. Boguslawska-Jaworska J; Dobryszycka W Arch Immunol Ther Exp (Warsz); 1967; 15(6):858-67. PubMed ID: 5587693 [No Abstract] [Full Text] [Related]
8. [Changes in the blood protein and amino acid levels in rheumatic diseases]. Shevel' EIa; Bagirova GG; Shevel' VA; Bagirova VV Ter Arkh; 1982; 54(10):87-9. PubMed ID: 7179129 [No Abstract] [Full Text] [Related]
9. CD5 positive B lymphocytes in seronegative juvenile arthritis. Martini A; Massa M; De Benedetti F; Viola S; Neirotti G; Burgio RG J Rheumatol; 1990 Jul; 17(7):932-5. PubMed ID: 1698986 [TBL] [Abstract][Full Text] [Related]
10. [Vasculitis associated with connectivitis]. Merazzi D; Parravicini D; Lietti D Pediatr Med Chir; 1989; 11 Suppl 1():43-55. PubMed ID: 2682546 [TBL] [Abstract][Full Text] [Related]
11. [Fibrin fibrinogen degradation products in the blood in systemic lupus erythematosus and other major collagen diseases]. Wysocka K; Kiczak J Reumatologia; 1982; 20(1-2):15-21. PubMed ID: 7163659 [No Abstract] [Full Text] [Related]
14. Large macrophage colony-forming cells identical to high proliferative potential colony-forming cells in peripheral blood of patients with collagen vascular diseases: high occurrence among patients with systemic sclerosis and dermatomyositis. Horie S; Minota S; Kano S J Rheumatol; 2000 Oct; 27(10):2378-81. PubMed ID: 11036833 [TBL] [Abstract][Full Text] [Related]
15. Fibrinogen in systemic lupus erythematosus: more than an acute phase reactant? Ames PR; Alves J; Pap AF; Ramos P; Khamashta MA; Hughes GR J Rheumatol; 2000 May; 27(5):1190-5. PubMed ID: 10813286 [TBL] [Abstract][Full Text] [Related]
16. Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosus. Heshmat NM; El-Kerdany TH Pediatr Allergy Immunol; 2007 Jun; 18(4):346-53. PubMed ID: 17346298 [TBL] [Abstract][Full Text] [Related]